This study is testing a new combination treatment for ovarian cancer that has returned after initial therapy. It involves delivering chemotherapy and an immune-boosting drug directly into the abdomen, along with an IV immunotherapy drug. The goal is to see if this intensive appro…
Phase: PHASE1, PHASE2 • Sponsor: Robert Edwards • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC